Michael Taylor
Vorsitzender bei Mitokinin, Inc.
Aktive Positionen von Michael Taylor
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Mission Biocapital (California)
 Mission Biocapital (California) Investment ManagersFinance BioInnovation LLC is a Angel firm, a subsidiary of BioInnovation LLC founded in 2018. BioInnovation LLC is headquartered in Cambridge. | Corporate Officer/Principal | - | - |
Telo Therapeutics, Inc.
 Telo Therapeutics, Inc. BiotechnologyHealth Technology Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality. | Direktor/Vorstandsmitglied | - | - |
Mitokinin, Inc.
 Mitokinin, Inc. BiotechnologyHealth Technology Mitokinin, Inc. develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases. The company was founded by Kevan Shokat, Nicholas Hertz, and Daniel de Roulet Jr. and is headquartered in New York, NY. | Vorsitzender | - | - |
BioInnovation Management LLC
 BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D. Parker and Susie T. Harborth. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01.01.2020 | - |
Karriereverlauf von Michael Taylor
Ehemalige bekannte Positionen von Michael Taylor
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2014 | 23.06.2021 |
| Vorstandsvorsitzender | 01.03.2014 | 18.03.2019 | |
| Präsident | 01.03.2014 | 18.03.2019 | |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.07.2007 | 01.10.2013 |
| Vorstandsvorsitzender | 01.07.2007 | 01.10.2013 | |
| Präsident | 01.07.2007 | 01.10.2013 | |
| ADHERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 26.07.2010 | 22.08.2012 |
| Independent Dir/Board Member | 11.05.2011 | 22.08.2012 | |
| ADHERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2010 | 01.01.2012 |
| ░░░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
Ausbildung von Michael Taylor
| State University of New York at Buffalo | Doctorate Degree |
| University of South Florida | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 15 |
Operativ
| Director/Board Member | 7 |
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Health Technology |
Ensemble Therapeutics Corp.
Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
| Warner-Lambert Co. LLC | |
Mission Biocapital (California)
Mission Biocapital (California) Investment ManagersFinance BioInnovation LLC is a Angel firm, a subsidiary of BioInnovation LLC founded in 2018. BioInnovation LLC is headquartered in Cambridge. | Finance |
Telo Therapeutics, Inc.
Telo Therapeutics, Inc. BiotechnologyHealth Technology Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality. | Health Technology |
Mitokinin, Inc.
Mitokinin, Inc. BiotechnologyHealth Technology Mitokinin, Inc. develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases. The company was founded by Kevan Shokat, Nicholas Hertz, and Daniel de Roulet Jr. and is headquartered in New York, NY. | Health Technology |
BioInnovation Management LLC
BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D. Parker and Susie T. Harborth. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Börse
- Insiders
- Michael Taylor
- Erfahrung
